Cerebrospinal fluid (CSF) lactate for distinguishing acute bacterial meningitis from acute viral meningitis in children
Date First Published:
July 20, 2018
Last Updated:
January 12, 2019
Report by:
Alexander Zozula, EMS Fellow (University of Cincinnati Department of Emergency Medicine)
Search checked by:
Christopher Stave, University of Cincinnati Department of Emergency Medicine
Three-Part Question:
In [non-neonatal children undergoing lumbar punctures for possible meningitis] what are [the sensitivity and specificity of CSF lactate] for [diagnosing acute community-acquired bacterial meningitis]?
Clinical Scenario:
You are evaluating a pediatric patient in the emergency department in whom you are considering the diagnosis of acute community-acquired bacterial meningitis. You perform a lumbar puncture and when ordering CSF studies wonder if sending a CSF lactate would help distinguish acute bacterial meningitis (ABM) from acute viral meningitis (AVM).
Search Strategy:
PubMed
((("bacteria"[mesh] OR "bacterial infections"[mesh]) AND ("meningitis"[mesh:noexp])) OR "meningitis, bacterial"[mesh] OR (mening*[tw] AND (bacteria*[tw] OR escherichia[tw] OR haemophilus[tw] OR listeria[tw] OR meningococc*[tw] OR neisseria[tw] OR pneumococc*[tw] OR streptococc*[tw]))
AND (“cerebrospinal fluid”[mesh] OR “cerebrospinal fluid”[subheading] OR “cerebrospinal fluid”[tw] OR “CSF”[tw]) AND (“lactates”[mesh] OR lacta*[tw] OR lacti*[tw]))
AND english[lang]
EMBASE
(((‘bacterium’/exp OR ‘bacterial infection’/exp) AND ‘meningitis’/exp) OR (mening*:ab,ti,kw AND (bacteria*:ab,ti,kw OR ‘escherichia’:ab,ti,kw OR ‘haemophilus’:ab,ti,kw OR listeria:ab,ti,kw OR meningococc*:ab,ti,kw OR ‘neisseria’:ab,ti,kw OR pneumococc*:ab,ti,kw OR streptococc*:ab,ti,kw)))
AND ((‘cerebrospinal fluid'/exp OR ‘cerebrospinal fluid’:ab,ti,kw OR ‘CSF’:ab,ti,kw) AND (‘lactic acid'/exp OR lact*:ab,ti,kw))
AND [english]/lim
((("bacteria"[mesh] OR "bacterial infections"[mesh]) AND ("meningitis"[mesh:noexp])) OR "meningitis, bacterial"[mesh] OR (mening*[tw] AND (bacteria*[tw] OR escherichia[tw] OR haemophilus[tw] OR listeria[tw] OR meningococc*[tw] OR neisseria[tw] OR pneumococc*[tw] OR streptococc*[tw]))
AND (“cerebrospinal fluid”[mesh] OR “cerebrospinal fluid”[subheading] OR “cerebrospinal fluid”[tw] OR “CSF”[tw]) AND (“lactates”[mesh] OR lacta*[tw] OR lacti*[tw]))
AND english[lang]
EMBASE
(((‘bacterium’/exp OR ‘bacterial infection’/exp) AND ‘meningitis’/exp) OR (mening*:ab,ti,kw AND (bacteria*:ab,ti,kw OR ‘escherichia’:ab,ti,kw OR ‘haemophilus’:ab,ti,kw OR listeria:ab,ti,kw OR meningococc*:ab,ti,kw OR ‘neisseria’:ab,ti,kw OR pneumococc*:ab,ti,kw OR streptococc*:ab,ti,kw)))
AND ((‘cerebrospinal fluid'/exp OR ‘cerebrospinal fluid’:ab,ti,kw OR ‘CSF’:ab,ti,kw) AND (‘lactic acid'/exp OR lact*:ab,ti,kw))
AND [english]/lim
Search Details:
Searches were most recently run on December 19, 2018.
Outcome:
PubMed -- 518 results
EMBASE -- 658 results
Total -- 742 unique results
108 full text articles were reviewed after screening titles/abstracts from which 38 original articles and two systematic reviews were ultimately selected for inclusion. For completeness, the original articles included in the two systematic reviews are listed below as there appear to be several minor discrepancies in the data abstracted in the systematic reviews.
EMBASE -- 658 results
Total -- 742 unique results
108 full text articles were reviewed after screening titles/abstracts from which 38 original articles and two systematic reviews were ultimately selected for inclusion. For completeness, the original articles included in the two systematic reviews are listed below as there appear to be several minor discrepancies in the data abstracted in the systematic reviews.
Relevant Paper(s):
| Study Title | Patient Group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
|---|---|---|---|---|---|
| Comparison between cerebrospinal fluid concentrations of glucose, total protein, chloride, lactate, and total amino acids for the differential diagnosis of patients with meningitis. Briem et al. 1983 Sweden | Single hospital Mean 44 vs. 29y ABM vs. AVM, 52% male n=45 ABM, n=102 AVM |
Cohort | Lactate cutoff | 3.5mM | Excluded ABM without organism identified |
| Sensitivity | 100% | ||||
| Specificity | 96.10% | ||||
| LR+ | 25.5 | ||||
| LR- | |||||
| Measurement of lactic acid in cerebrospinal fluid of patients with infections of the central nervous system. Brook et al. 1978 USA | Single hospital 54% adults n=25 ABM, n=26 AVM |
Cohort | Lactate cutoff | 3.9mM using chromatography | Excluded ABM without organism identified |
| Sensitivity | 100% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | |||||
| The clinical diagnostic significance of cerebrospinal fluid d-lactate for bacterial meningitis. Chen et al. 2012 China | Single hospital Mean 43±15 vs. 32±17y, 45% vs. 67% male ABM vs. AVM n=21 ABM, n=30 AVM |
Cohort | Lactate cutoff | 3.3mM | Included patients pretreated with antibiotics/steroids |
| Sensitivity | 71.40% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | 0.286 | ||||
| Cerebrospinal fluid lactate and the diagnosis of meningitis. Curtis et al. 1981 UK | Two hospitals Unknown demographics n=10 ABM, n=12 AVM |
Cohort | Lactate cutoff | 2.8mM | Excluded ABM without organism identified |
| Sensitivity | 100% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | |||||
| Cerebrospinal fluid lactic acid: a valuable aid in the of diagnosis septic meningitis. Ellis and Oei 1979 USA | Single hospital Unknown demographics n=10 ABM, n=12 "CNS inflammation" including AVM |
Cohort | Lactate cutoff | 5.0mM | Excluded ABM without organism identified "CNS inflammation" group included not only AVM but also leukemia, ICH, MS, and "hypoxic seizures" |
| Sensitivity | 100% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | |||||
| Gas liquid chromatography in the rapid diagnosis of meningitis. Ferguson and Tearle 1977 UK | Single hospital Unknown demographics n=8 ABM, n=15 AVM |
Cohort | Lactate cutoff | 5.6mM using chromatography | Unclear definition of ABM Included patients pretreated with antibiotics |
| Sensitivity | 100% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | |||||
| Rapid diagnosis of meningitis with use of selected clinical data and gas-liquid chromatographic determination of lactate concentration in cerebrospinal fluid. Gastrin et al. 1979 Sweden | Single hospital Median 33 vs. 54 vs. 24y ABM vs. presumed ABM vs. AVM n=38 ABM, n=5 presumed ABM, n=17 AVM |
Cohort | Lactate cutoff | 3.5mM using chromatography | Included patients pretreated with antibiotics |
| Sensitivity | 95.30% | ||||
| Specificity | 82.40% | ||||
| LR+ | 5.4 | ||||
| LR- | 0.056 | ||||
| Use of cerebrospinal fluid lactate levels in the diagnosis of bacterial meningitis. Hurd et al. 1978 USA | Single affiliated adult/children hospital 77% adult n=11 ABM, n=80 comparator group including AVM |
Cohort | Lactate cutoff | 3.4mM using chromatography | Excluded ABM without organism identified Comparator group included not only AVM but also ICH, cancer, and post-neurosurgical patients |
| Sensitivity | 100% | ||||
| Specificity | 97.50% | ||||
| LR+ | 40 | ||||
| LR- | |||||
| CSF lactate in diseases of the CNS. Jordan et al. 1983 USA | Single hospital Unknown demographics n=7 ABM, n=3 AVM |
Cohort | Lactate cutoff | 3.0mM | Excluded ABM without organism identified n=3 AVM makes the specificity extraordinarily fragile |
| Sensitivity | 100% | ||||
| Specificity | 66.70% | ||||
| LR+ | 3 | ||||
| LR- | |||||
| Chemical analyses for early differential diagnosis between bacterial and viral meningitis. Landaas and Von Der Lippe 1985 Norway | Single hospital 47% vs. 52% male ABM vs. AVM n=19 ABM, n=24 AVM |
Cohort | Lactate cutoff | 6.0mM | Included patients pretreated with antibiotics Excluded ABM without organism identified |
| Sensitivity | 84.20% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | 0.158 | ||||
| Value of CSF lactate in the differential diagnosis between bacterial meningitis and other diseases with meningeal involvement. Lester et al. 1985 Denmark | Multicenter Unknown demographics n=16 ABM, n=15 AVM |
Cohort | Lactate cutoff | 3.5mM | Included patients pretreated with antibiotics |
| Sensitivity | 93.80% | ||||
| Specificity | 86.70% | ||||
| LR+ | 7.03 | ||||
| LR- | 0.072 | ||||
| Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection. Lindquist et al. 1988 Sweden | Multicenter Unknown demographics n=63 ABM, n=616 comparator group including AVM |
Cohort | Lactate cutoff | 3.5mM | ABM group included TB meningitis Comparator group included not only AVM but also "unclassified meningitis", other infectious CNS conditions, seizures, and strokes More favorable results listed correspond to patients <=15y, however, unknown number of patients <=15y |
| Sensitivity | 88.9%/97.0% | ||||
| Specificity | 96.4%/99.0% | ||||
| LR+ | 24.9/97.0 | ||||
| LR- | 0.115/0.030 | ||||
| How useful is cerebrospinal fluid lactate estimation in differential diagnosis of meningitis? Mandal et al. 1983 UK | Single hospital Unknown demographics n=20 ABM, n=59 AVM |
Cohort | Lactate cutoff | 4.3mM | |
| Sensitivity | 100% | ||||
| Specificity | 98.30% | ||||
| LR+ | 59 | ||||
| LR- | |||||
| The differential diagnosis of bacterial and aseptic meningitis using cerebrospinal fluid laboratory tests. Ponka et al. 1983 Finland | Single hospital Unknown demographics n=11 ABM, n=27 AVM |
Cohort | Lactate cutoff | 3.0mM | Excluded ABM without organism identified |
| Sensitivity | 90.90% | ||||
| Specificity | 96.30% | ||||
| LR+ | 24.5 | ||||
| LR- | 0.094 | ||||
| Quantitation of cerebrospinal fluid lactic acid in infectious and non-infectious neurological diseases. de Almeida et al. 2009 Brazil | Single hospital Mean 21±20y, 53% male n=20 ABM, n=41 AVM |
Cohort | Lactate cutoff | 3.5mM using Date Behring analyzer | |
| Sensitivity | 80% | ||||
| Specificity | 97.60% | ||||
| LR+ | 32.8 | ||||
| LR- | 0.205 | ||||
| Cerebrospinal fluid lactate in the diagnosis of meningitis. Diagnostic value compared to standard biochemical methods. Berg et al. 1982 Sweden | Multicenter Mean 30 vs. 21y ABM vs. AVM n=18 ABM, n=121 AVM |
Cohort | Lactate cutoff | 3.0mM | Excluded ABM without organism identified |
| Sensitivity | 88.90% | ||||
| Specificity | 92.60% | ||||
| LR+ | 12 | ||||
| LR- | 0.12 | ||||
| Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis. Huy et al. 2010 | 25 studies included (both adults and children) n=783 ABM, n=909 AVM |
Systematic review and meta-analysis | AUC CSF lactate | 0.984 | Excluded non-English studies No gray literature Excluded studies with n<8 for either ABM or AVM Excluded studies with comparator groups including but not exclusively comprised of AVM |
| AUC CSF WBC | 0.948 | ||||
| AUC CSF glucose | 0.881 | ||||
| AUC CSF/plasma glucose | 0.952 | ||||
| AUC CSF protein | 0.862 | ||||
| Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: A meta-analysis. Sakushima et al. 2011 | 33 studies included (both adults and children) n=934 ABM, n=951 AVM |
Systematic review and meta-analysis | Sensitivity | 93% | Excluded non-English studies No gray literature Excluded studies with comparator groups including but not exclusively comprised of AVM |
| Specificity | 96% | ||||
| LR+ | 22.9 | ||||
| LR- | 0.07 | ||||
| Assessment of five laboratory tests for differential diagnosis in bacterial and viral meningoencephalitides. Juarez Aragon et al. 1979 Mexico | Single hospital Unknown demographics n=23 ABM, n=21 AVM |
Cohort | Lactate cutoff | 2.2mM | Unclear definition of ABM |
| Sensitivity | 100% | ||||
| Specificity | 95.20% | ||||
| LR+ | 21 | ||||
| LR- | |||||
| Cerebrospinal fluid lactic acid level and pH in meningitis. Aids in differential diagnosis. Bland et al. 1974 USA | Single hospital 12 vs. 18mo ABM vs. AVM n=15 ABM, n=25 AVM |
Cohort | Lactate cutoff | 4.5mM | Excluded ABM without organism identified |
| Sensitivity | 93.30% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | 0.067 | ||||
| Bacterial meningitis and cerebrospinal fluid lactate. Boon and Heng 1978 Singapore | Single hospital Unknown demographics n=6 ABM, n=13 AVM |
Cohort | Lactate cutoff | 2.4mM | |
| Sensitivity | 100% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | |||||
| Cerebrospinal fluid lactate in meningitis and meningococcaemia. Cameron et al. 1993 UK | Single hospital Unknown demographics n=11 ABM, n=9 AVM |
Cohort | Lactate cutoff | 4.1mM | Excluded ABM without organism identified |
| Sensitivity | 100% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | |||||
| Diagnosis of pyogenic meningitis. Controni and Rodriguez 1976 USA | Single hospital Unknown demographics n=21 ABM, n=171 "non-bacterial cases" including AVM |
Cohort | Lactate cutoff | 3.4mM using chromatography | Excluded ABM without organism identified Comparator group included not only AVM Likely overlap in patients with Controni et al., 1977 |
| Sensitivity | 100% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | |||||
| Cerebrospinal fluid lactic acid levels in meningitis. Controni et al. 1977 USA | Single hospital Unknown demographics n=55 ABM, n=15 AVM |
Cohort | Lactate cutoff | 2.8mM | Included patients pretreated with antibiotics Excluded ABM without organism identified Likely overlap in patients with Controni and Rodriguez, 1976 |
| Sensitivity | 96.40% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | 0.036 | ||||
| Cerebrospinal fluid lactate and lactate dehydrogenase activity in the rapid diagnosis of bacterial meningitis. Donald and Malan 1986 South Africa | Single hospital Median 17 vs. 60mo ABM vs. AVM n=43 ABM, n=23 AVM |
Cohort | Lactate cutoff | 2.85mM | Excluded ABM without organism identified |
| Sensitivity | 93.00% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | 0.07 | ||||
| Diagnostic use of cerebrospinal fluid lactic acid levels in meningitis. Dwivedi and Reddy 1983 USA | Single hospital Mean 2y vs. 7y ABM vs. AVM n=9 ABM, n=3 AVM |
Cohort | Lactate cutoff | 3.9mM | n=3 AVM makes the specificity extraordinarily fragile |
| Sensitivity | 100% | ||||
| Specificity | 66.70% | ||||
| LR+ | 3 | ||||
| LR- | |||||
| Cerebrospinal fluid lactic acidosis in bacterial meningitis. Eross et al. 1981 Australia | Single hospital Median 1 vs. 5 vs. 4y ABM vs. AVM vs. presumed AVM n=66 ABM, n=31 AVM, n=58 presumed AVM |
Cohort | Lactate cutoff | 3.9mM | Included patients pretreated with antibiotics Excluded ABM without organism identified |
| Sensitivity | 97.00% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | 0.03 | ||||
| Early (chemical) diagnosis of bacterial meningitis--cerebrospinal fluid glucose, lactate, and lactate dehydrogenase compared. Knight et al. 1981 USA | Single ED Unknown demographics n=68 ABM, n=20 AVM |
Cohort | Lactate cutoff | 3.4mM | Excluded culture negative ABM |
| Sensitivity | 100% | ||||
| Specificity | 85% | ||||
| LR+ | 6.67 | ||||
| LR- | |||||
| Cerebrospinal fluid lactate--its diagnostic value in septic meningitis. Low et al. 1986 Singapore | Single hospital Mean 21±31 vs. 46±43mo, 38% vs. 74% male ABM vs. AVM n=22 ABM, n=54 AVM |
Cohort | Lactate cutoff | 2.8mM | Included patients pretreated with antibiotics Excluded ABM without organism identified |
| Sensitivity | 86.40% | ||||
| Specificity | 85.20% | ||||
| LR+ | 5.83 | ||||
| LR- | 0.16 | ||||
| Cerebrospinal fluid lactate level as a diagnostic biomarker for bacterial meningitis in children. Filho et al. 2014 Brazil | Single ED Mean 5y, 68% male n=40 ABM, n=411 AVM |
Cohort | Lactate cutoff | 3.0mM | Excluded ABM without organism identified No mention of lactate assay method and no reply from author Excluded patients with "critical illness" and concurrent alternative infection requiring parenteral antibiotics |
| Sensitivity | 95% | ||||
| Specificity | 93.70% | ||||
| LR+ | 15 | ||||
| LR- | 0.053 | ||||
| The diagnostic value of cerebrospinal fluid lactic acid levels in meningitis. Murata and Uemura 1981 Japan | Single hospital Unknown demographics n=2 ABM, n=18 AVM |
Cohort | Lactate cutoff | 3.4mM using chromatography | Excluded ABM without organism identified Excluded AVM without organism identified n=2 ABM makes the sensitivity extraordinarily fragile |
| Sensitivity | 100% | ||||
| Specificity | 94.40% | ||||
| LR+ | 18 | ||||
| LR- | |||||
| Cerebrospinal fluid lactate: a differential biomarker for bacterial and viral meningitis in children. Nazir et al. 2018 India | Single ED Mean 14 vs. 63m, 30% vs. 40% male ABM vs. AVM n=60 ABM, n=156 AVM |
Cohort | Lactate cutoff | 3.0mM using Instrumentation Laboratory analyzer | Excluded patients with "critical illness" and concurrent alternative infections (e.g. pneumonia) |
| Sensitivity | 90% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | 0.1 | ||||
| The diagnostic and predictive value of cerebrospinal fluid lactate in children with meningitis. Its relation to current diagnostic methods. Nelson et al. 1986 Sweden | Single hospital 59% male n=11 ABM, n=28 AVM |
Cohort | Lactate cutoff | 2.4mM | Excluded ABM without organism identified |
| Sensitivity | 100% | ||||
| Specificity | 89.30% | ||||
| LR+ | 9.33 | ||||
| LR- | |||||
| Is the CSF lactate measurement useful in the management of children with suspected bacterial meningitis? Rutledge et al. 1981 USA | Single hospital Unknown demographics n=29 ABM, n=13 AVM |
Cohort | Lactate cutoff | 3.0mM | Included patients pretreated with antibiotics Excluded ABM without organism identified |
| Sensitivity | 93.10% | ||||
| Specificity | 69.20% | ||||
| LR+ | 3.03 | ||||
| LR- | 0.1 | ||||
| CSF lactate in bacterial meningitis with minimal CSF abnormalities. Ruuskanen et al. 1985 Finland | Single hospital Unknown demographics n=32 ABM, n=30 AVM |
Cohort | Lactate cutoff | 3.0mM | Excluded ABM without organism identified |
| Sensitivity | 93.80% | ||||
| Specificity | 93.30% | ||||
| LR+ | 14.1 | ||||
| LR- | 0.067 | ||||
| Cerebrospinal fluid lactic acid concentration in bacterial meningitis. Pit et al. 1987 Malaysia | Single hospital Unknown demographics n=15 ABM, n=4 AVM |
Cohort | Lactate cutoff | 3.4mM using chromatography | Excluded ABM without organism identified and cases with organisms thought to represent contamination n=4 AVM makes the specificity extraordinarily fragile |
| Sensitivity | 100% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | |||||
| Diagnostic value of lactate, procalcitonin, ferritin, serum-C-reactive protein, and other biomarkers in bacterial and viral meningitis. Dashti et al. 2017 Iran | Single hospital Mean 43mo, 60% male n=12 ABM, n=38 AVM |
Cohort | Lactate cutoff | 3.4mM | |
| Sensitivity | 91.70% | ||||
| Specificity | 89.50% | ||||
| LR+ | 8.71 | ||||
| LR- | 0.093 | ||||
| Cerebrospinal fluid lactate is useful in differentiating viral from bacterial meningitis. Shaltout 1989 Kuwait | Single hospital Unknown demographics n=15 ABM, n=9 AVM |
Cohort | Lactate cutoff | 3.0mM | |
| Sensitivity | 93.30% | ||||
| Specificity | 88.90% | ||||
| LR+ | 8.4 | ||||
| LR- | 0.075 | ||||
| Haemophilus influenzae type b still remains a leading cause of meningitis among unvaccinated children--a prospective CSF analysis study. Uduman et al. 2000 UAE | Single hospital Median 5 vs. 18mo ABM vs. AVM n=23 ABM, n=42 comparator group including AVM |
Cohort | Lactate cutoff | Not reported | Comparator group included not only AVM but also febrile seizures, GBS, peripheral neuropathies, and metabolic disorders |
| Sensitivity | 95.70% | ||||
| Specificity | 92.90% | ||||
| LR+ | 13.4 | ||||
| LR- | 0.047 | ||||
| Cerebrospinal fluid lactate level in childhood purulent meningitis. Vanprapar et al. 1983 Thailand | Single hospital Mean 25 vs. 9 vs. 46mo, 85% vs. 44% vs. 55% male ABM vs. presumed ABM vs. AVM n=13 ABM, n=9 presumed ABM, n=18 AVM |
Cohort | Lactate cutoff | 3.9mM | |
| Sensitivity | 90.90% | ||||
| Specificity | 100% | ||||
| LR+ | Infinity | ||||
| LR- | 0.091 |
Author Commentary:
Distinguishing acute bacterial meningitis from acute viral meningitis can be challenging. While a strategy of treating all possible cases of ABM with broad spectrum antibiotics until CSF cultures result is commonly employed, this strategy may lead to antibiotic resistance and unnecessary hospitalization. A combination of CSF white blood cell count/differential, CSF glucose, and CSF protein is commonly used to distinguish ABM from AVM. Unfortunately these tests all suffer from suboptimal sensitivity and specificity. The ideal test would be maximally sensitive and specific, rapidly available, and cheap. Despite not being commonly used, CSF lactate has been widely studied and appears to satisfy all three domains. The median cutoff used in the included studies was 3.4mM (~30mg/dL), with the majority of studies using enzymatic assays. As with most CSF tests including the gold-standard culture, CSF lactate's utility is somewhat limited in patients pretreated with antibiotics. In such cases, a lower cutoff should be used to maintain sufficient sensitivity.
Bottom Line:
CSF lactate at a cutoff of 3.5mM appears to be both a sensitive and specific test for distinguishing acute bacterial meningitis from acute viral meningitis in non-neonatal children. With nearly 40 studies supporting its use over the past 40 years, it appears ready for routine use.
Level of Evidence:
Level 1: Recent well-done systematic review was considered or a study of high quality is available
References:
- Briem et al.. Comparison between cerebrospinal fluid concentrations of glucose, total protein, chloride, lactate, and total amino acids for the differential diagnosis of patients with meningitis.
- Brook et al.. Measurement of lactic acid in cerebrospinal fluid of patients with infections of the central nervous system.
- Chen et al.. The clinical diagnostic significance of cerebrospinal fluid d-lactate for bacterial meningitis.
- Curtis et al.. Cerebrospinal fluid lactate and the diagnosis of meningitis.
- Ellis and Oei. Cerebrospinal fluid lactic acid: a valuable aid in the of diagnosis septic meningitis.
- Ferguson and Tearle. Gas liquid chromatography in the rapid diagnosis of meningitis.
- Gastrin et al.. Rapid diagnosis of meningitis with use of selected clinical data and gas-liquid chromatographic determination of lactate concentration in cerebrospinal fluid.
- Hurd et al.. Use of cerebrospinal fluid lactate levels in the diagnosis of bacterial meningitis.
- Jordan et al.. CSF lactate in diseases of the CNS.
- Landaas and Von Der Lippe. Chemical analyses for early differential diagnosis between bacterial and viral meningitis.
- Lester et al.. Value of CSF lactate in the differential diagnosis between bacterial meningitis and other diseases with meningeal involvement.
- Lindquist et al.. Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection.
- Mandal et al.. How useful is cerebrospinal fluid lactate estimation in differential diagnosis of meningitis?
- Ponka et al.. The differential diagnosis of bacterial and aseptic meningitis using cerebrospinal fluid laboratory tests.
- de Almeida et al.. Quantitation of cerebrospinal fluid lactic acid in infectious and non-infectious neurological diseases.
- Berg et al.. Cerebrospinal fluid lactate in the diagnosis of meningitis. Diagnostic value compared to standard biochemical methods.
- Huy et al.. Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis.
- Sakushima et al.. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: A meta-analysis.
- Juarez Aragon et al.. Assessment of five laboratory tests for differential diagnosis in bacterial and viral meningoencephalitides.
- Bland et al.. Cerebrospinal fluid lactic acid level and pH in meningitis. Aids in differential diagnosis.
- Boon and Heng. Bacterial meningitis and cerebrospinal fluid lactate.
- Cameron et al.. Cerebrospinal fluid lactate in meningitis and meningococcaemia.
- Controni and Rodriguez. Diagnosis of pyogenic meningitis.
- Controni et al.. Cerebrospinal fluid lactic acid levels in meningitis.
- Donald and Malan. Cerebrospinal fluid lactate and lactate dehydrogenase activity in the rapid diagnosis of bacterial meningitis.
- Dwivedi and Reddy. Diagnostic use of cerebrospinal fluid lactic acid levels in meningitis.
- Eross et al.. Cerebrospinal fluid lactic acidosis in bacterial meningitis.
- Knight et al.. Early (chemical) diagnosis of bacterial meningitis--cerebrospinal fluid glucose, lactate, and lactate dehydrogenase compared.
- Low et al.. Cerebrospinal fluid lactate--its diagnostic value in septic meningitis.
- Filho et al.. Cerebrospinal fluid lactate level as a diagnostic biomarker for bacterial meningitis in children.
- Murata and Uemura. The diagnostic value of cerebrospinal fluid lactic acid levels in meningitis.
- Nazir et al.. Cerebrospinal fluid lactate: a differential biomarker for bacterial and viral meningitis in children.
- Nelson et al.. The diagnostic and predictive value of cerebrospinal fluid lactate in children with meningitis. Its relation to current diagnostic methods.
- Rutledge et al.. Is the CSF lactate measurement useful in the management of children with suspected bacterial meningitis?
- Ruuskanen et al.. CSF lactate in bacterial meningitis with minimal CSF abnormalities.
- Pit et al.. Cerebrospinal fluid lactic acid concentration in bacterial meningitis.
- Dashti et al.. Diagnostic value of lactate, procalcitonin, ferritin, serum-C-reactive protein, and other biomarkers in bacterial and viral meningitis.
- Shaltout. Cerebrospinal fluid lactate is useful in differentiating viral from bacterial meningitis.
- Uduman et al.. Haemophilus influenzae type b still remains a leading cause of meningitis among unvaccinated children--a prospective CSF analysis study.
- Vanprapar et al.. Cerebrospinal fluid lactate level in childhood purulent meningitis.
